BPA for haegarda
Ended Awarded Last action
- Contract number
- 36E79721A0024
- Awardee
-
CSL Behring L.L.C. UEI H3WKVE9VBLY3
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 1 $87,957 obligated
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Combined order value
- $87,957 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 1% used
- $17,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
CSL Behring L.L.C., a global biotherapeutics company headquartered in King of Prussia, Pennsylvania, was awarded a single-award Blanket Purchase Agreement by the National Acquisition Center on September 30, 2021, for the procurement of HAEGARDA, a C1 inhibitor medication used to treat hereditary angioedema. The BPA carries a ceiling value of $17.5 million and extends through September 29, 2026, with performance conducted at CSL Behring's manufacturing and distribution facility in King of Prussia, Pennsylvania. As a civilian procurement for the Department of Veterans Affairs, this agreement utilizes firm fixed pricing with no set-aside designations applied, reflecting CSL Behring's status as a large enterprise contractor. The BPA serves as a primary vehicle for coordinated supply of HAEGARDA across the Veterans Health Administration system, enabling efficient procurement through pre-negotiated pricing and terms for VA medical facilities nationwide.
Under this BPA, the Veterans Affairs Greater Los Angeles Healthcare System Pharmacy issued a task order call on February 21, 2022, valued at approximately $87,957 for HAEGARDA drug procurement, with completion scheduled for March 21, 2022. This call exemplifies the operational structure wherein individual Veterans Integrated Service Networks execute delivery orders against the master BPA for their respective pharmacy needs. CSL Behring also supplies related specialty pharmaceutical products including Privigen, Hizentra, and Kcentra through the broader Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), which carries a ceiling value of approximately $201.5 million through September 2026. The coordinated use of these IDVs enables the Veterans Health Administration to maintain consistent access to critical hereditary angioedema treatments and related hematology therapies across multiple regional service networks while leveraging pre-established pricing arrangements.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Haegarda drug purchase for VA GLA HCS pharmacy | Veterans Integrated Service Network 22 (VHA) | $87,957 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79721A0024?
36E79721A0024 was awarded to CSL Behring L.L.C. by National Acquisition Center (Headquarters) on September 30, 2021.
How much is contract 36E79721A0024 worth?
Orders under 36E79721A0024 have obligated $87,957. 36E79721A0024's own ceiling is $17,500,000.
How many orders have been placed under contract 36E79721A0024?
1 order has been placed under 36E79721A0024, the latest on February 21, 2022.
Who can order from contract 36E79721A0024?
36E79721A0024 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79721A0024 under another contract?
Yes. 36E79721A0024 is a blanket purchase agreement under 36F79721D0249, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79721A0024 competed?
The extent of competition for 36E79721A0024 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV